Q4 2021 Results slide image

Q4 2021 Results

Participants Company overview Pharmaceuticals Oncology Financial review Conclusion Appendix Susanne Schaffert President, Novartis Oncology 32 Investor Relations | Q4 2021 Results 1 NOVARTIS | Reimagining Medicine
View entire presentation